(Q37393013)

20 August 2017

1 reference

title

The chemokine receptors CXCR4 and CXCR3 in cancer (English)

1 reference

20 August 2017

Amy M Fulton

1

1 reference

20 August 2017

1 March 2009

1 reference

20 August 2017

Current Oncology Reports

1 reference

20 August 2017

11

1 reference

20 August 2017

2

1 reference

20 August 2017

125-131

1 reference

https://scigraph.springernature.com/pub.10.1007/s11912-009-0019-1

20 August 2017

0 references

cites work

Identification and partial characterization of a variant of human CXCR3 generated by posttranscriptional exon skipping

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11912-009-0019-1

CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors

21 January 2018

1 reference

12 December 2020

Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB-435 and MCF-7 cells: relevance for the development of human breast cancer

1 reference

12 December 2020

CXCR4 regulates growth of both primary and metastatic breast cancer

1 reference

12 December 2020

Immunotherapy with interleukin-10 depends on the CXC chemokines inducible protein-10 and monokine induced by IFN-gamma.

1 reference

12 December 2020

Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion

1 reference

12 December 2020

The significance of cancer cell expression of the chemokine receptor CXCR4.

1 reference

12 December 2020

The expression of the chemokine receptor CXCR3 and its ligand, CXCL10, in human breast adenocarcinoma cell lines

1 reference

12 December 2020

Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer

1 reference

12 December 2020

An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4

1 reference

12 December 2020

Androgen receptor negatively influences the expression of chemokine receptors (CXCR4, CCR1) and ligand-mediated migration in prostate cancer DU-145.

1 reference

12 December 2020

Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes

1 reference

12 December 2020

CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma

1 reference

12 December 2020

CXCL12/CXCR4 transactivates HER2 in lipid rafts of prostate cancer cells and promotes growth of metastatic deposits in bone

1 reference

12 December 2020

Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4.

1 reference

12 December 2020

Down-modulation of CXCR3 surface expression and function in CD8+ T cells from cutaneous T cell lymphoma patients

1 reference

12 December 2020

Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells

1 reference

12 December 2020

Immune-mediated modulation of breast cancer growth and metastasis by the chemokine Mig (CXCL9) in a murine model

1 reference

12 December 2020

Transactivation of CXCR4 by the insulin-like growth factor-1 receptor (IGF-1R) in human MDA-MB-231 breast cancer epithelial cells

1 reference

12 December 2020

CXC chemokine receptor-4 antagonist blocks both growth of primary tumor and metastasis of head and neck cancer in xenograft mouse models

1 reference

12 December 2020

The chemokine receptor CXCR3 is an independent prognostic factor in patients with localized clear cell renal cell carcinoma

1 reference

12 December 2020

T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer

1 reference

12 December 2020

Organ selectivity in metastasis: regulation by chemokines and their receptors

1 reference

12 December 2020

A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors.

1 reference

12 December 2020

Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer

1 reference

12 December 2020

Involvement of chemokine receptors in breast cancer metastasis

1 reference

12 December 2020

CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model.

1 reference

12 December 2020

Endothelial cells and normal breast epithelial cells enhance invasion of breast carcinoma cells by CXCR-4-dependent up-regulation of urokinase-type plasminogen activator receptor (uPAR, CD87) expression.

1 reference

12 December 2020

Blocking CXCR4-mediated cyclic AMP suppression inhibits brain tumor growth in vivo

1 reference

12 December 2020

IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo

1 reference

12 December 2020

CXCL10 promotes invasion-related properties in human colorectal carcinoma cells

1 reference

12 December 2020

Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases

1 reference

12 December 2020

Cellular characteristics of neuroblastoma cells: regulation by the ELR--CXC chemokine CXCL10 and expression of a CXCR3-like receptor

1 reference

12 December 2020

The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia

1 reference

12 December 2020

Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes

1 reference

12 December 2020

Post-transcriptional regulation of chemokine receptor CXCR4 by estrogen in HER2 overexpressing, estrogen receptor-positive breast cancer cells

1 reference

12 December 2020

Differential functional activation of chemokine receptor CXCR4 is mediated by G proteins in breast cancer cells.

1 reference

12 December 2020

Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo.

1 reference

12 December 2020

10.1007/S11912-009-0019-1

Identifiers

DOI

1 reference

20 August 2017

1 reference

PubMed ID

19216844